“THE Food and Drug Administration is probably seeing some of its worst days ever,” says Michael Jacobson, director of the Center for Science in the Public Interest in Washington DC, and a member of the Coalition for a Stronger FDA.
The coalition, which is composed of patient, consumer and professional groups, was formed on Monday, three days after a report by the National Academy of Sciences’ Institute of Medicine in Washington DC found serious faults with the agency responsible for evaluating the safety of prescription drugs.
The main concerns raised by the report were underfunding, a lack of clear regulatory…
